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ORIGINAL ARTICLE
Prenatal maternal immune activation causes epigenetic
differences in adolescent mouse brain
P Basil1, Q Li1, EL Dempster2, J Mill2,3, P-C Sham1,4, CCY Wong3 and GM McAlonan1,5
Epigenetic processes such as DNA methylation have been implicated in the pathophysiology of neurodevelopmental disorders
including schizophrenia and autism. Epigenetic changes can be induced by environmental exposures such as inflammation. Here
we tested the hypothesis that prenatal inflammation, a recognized risk factor for schizophrenia and related neurodevelopmental
conditions, alters DNA methylation in key brain regions linked to schizophrenia, namely the dopamine rich striatum and endocrine
regulatory centre, the hypothalamus. DNA methylation across highly repetitive elements (long interspersed element 1 (LINE1) and
intracisternal A-particles (IAPs)) were used to proxy global DNA methylation. We also investigated the Mecp2 gene because it
regulates transcription of LINE1 and has a known association with neurodevelopmental disorders. Brain tissue was harvested from
6 week old offspring of mice exposed to the viral analog PolyI:C or saline on gestation day 9. We used Sequenom EpiTYPER assay to
quantitatively analyze differences in DNA methylation at IAPs, LINE1 elements and the promoter region of Mecp2. In the
hypothalamus, prenatal exposure to PolyI:C caused significant global DNA hypomethylation (t= 2.44, P= 0.019, PolyI:C mean
69.67%, saline mean 70.19%), especially in females, and significant hypomethylation of the promoter region of Mecp2, (t= 3.32,
P= 0.002; PolyI:C mean 26.57%, saline mean 34.63%). IAP methylation was unaltered. DNA methylation in the striatum was not
significantly altered. This study provides the first experimental evidence that exposure to inflammation during prenatal life is
associated with epigenetic changes, including Mecp2 promoter hypomethylation. This suggests that environmental and genetic risk
factors associated with neurodevelopmental disorders may act upon similar pathways. This is important because epigenetic
changes are potentially modifiable and their investigation may open new avenues for treatment.
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INTRODUCTION
Epigenetic processes are crucial for the regulation of genomic
function and development.1 For example, DNA methylation is
implicated in X-inactivation, genomic imprinting control and
remote silencing of genomic regions.2 Tissue-specific epigenetic
modifications through CpG methylation are thought to modulate
brain development, circadian rhythm and disease status.3–5
Consistent with this, epigenetic anomalies have been linked to
complex neurodevelopmental disorders including schizophrenia
and autism spectrum disorders.6,7
In early brain development, environmental exposures such as
inflammation,8 diet,9,10 toxins and contaminants11 disrupt devel-
opmental trajectories. For example, prenatal exposure to inflam-
mation has been implicated in the etiology of schizophrenia12
autism13 and bipolar disorder.14 Direct evidence supporting a role
for maternal immune activation (MIA) during prenatal life in
neurodevelopmental conditions has come from rodent studies
from our group and others.15–17 The consensus is that the MIA
model mimics many features relevant to schizophrenia and autism
in humans.18,19
Although not a genetic model, gene and protein expression
differences have consistently been reported in MIA rodent models,
including in the adult frontal cortex20 and the fetal whole
brain.17,21,22 In an MIA model elicited by exposing pregnant
rodents to the viral analog Polyinosinic:polycytidylic acid (PolyI:C),
interleukin 6 (IL6)-induced inflammation has been shown to exert
an epigenetic influence by regulating the methyltransferase
gene.23 Consistent with this, IL6 is been shown to alter global
DNA methylation in diseases such as oral cancer;24 however, it is
unknown whether this occurs in the brain of offspring exposed
to MIA.
One function of DNA methylation is to repress the transcription
of repetitive retroviral elements in the genome including long
interspersed element 1 (LINE1) or intracisternal A-particles (IAPs).
IAPs are endogenous retroviral sequences, an important class of
transposable elements that ‘jump’ within the genome inducing
genomic mutations and cell transformation. LINE1 elements are
retrotransposons - a subclass of transposons that also modulate
gene expression, especially in the developing brain.25 However,
whether prenatal exposure to maternal inflammation alters
methylation state of these repetitive elements has not been
directly examined.
An important target for epigenetic modification in models of
neurodevelopment is the Methyl CpG-binding protein2 (Mecp2).26
MECP2 is involved in the timely activation and repression of gene
expression. It has an important role in control of methylation27
and has a regulatory role in neuronal transcription of LINE1.25 It is
strongly associated with neurodevelopmental disorders such as
Rett syndrome,28 autism,29 schizophrenia and neural tube
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defects.30,31 To date however, whether Mecp2 is epigenetically
altered in the MIA model has not been investigated.
In this study we tested the hypothesis that prenatal exposure to
MIA in the mouse results in global methylation differences in the
brain and specifically alters DNA methylation in the promoter of
Mecp2. We elected to study the striatum because of its established
association with schizophrenia32 and autism,33 and the hypotha-
lamus that has an important influence on the limbic system and is
thought to have a critical role in the onset of prodromal features
of schizophrenia during the pubertal/postpubertal period.34,35
MATERIALS AND METHODS
Animal model of neurodevelopmental disorders
Female and male C57BL/6N mice were bred and mated in the Laboratory
Animal Unit, The University of Hong Kong. The holding space had a 12:12 h
normal light–dark cycle (lights off at 1900 hours), and temperature and
humidity-controlled (21 ± 1 °C, 55 ± 5%) animal vivarium. Pregnant females
were not disturbed, except for weekly cage-cleaning. Animals were
maintained under ad libitum food and water supplied by the Laboratory
Animal Unit. All experiments were performed in accordance with the
relevant institutional and national guidelines and regulations approved by
the Committee on the Use of Live Animals in Teaching and Research at The
University of Hong Kong, and every effort was made to minimize the
number of animals used and their suffering.
The MIA model was prepared following the procedures previously
reported in our laboratory and others.18,36 Potassium salt of PolyI:C was
obtained from Sigma-Aldrich (Gillingham, UK) and dissolved in saline. A
dose of 5 mg kg− 1 in an injection volume of 5ml kg− 1, prepared on the
day of injection, was administered to pregnant dams on gestation day 9
via the tail vein under gentle physical restraint. The resulting offsprings
were weaned and sexed at postnatal day 21. The pups were weighed and
littermates of the same sex were caged three to four per cage.
At 6 weeks, mice were killed by cervical dislocation, and their brains
were removed quickly. The hypothalamus and striatum were collected in
1.5-ml tubes using careful dissection methods referring the Allen Mouse
Brain Atlas37 and frozen in liquid nitrogen for storage. Ten to fifty
milligrams of brain tissue were homogenized on ice in a new reaction tube
with freshly made and autoclaved lysis buffer (10mM Tris-HCl, 0.1 M EDTA,
0.5% sodium dodecyl sulfate) using a DNase-free, sterile plastic pestle.
Samples were lysed by incubation with 300ml of lysis buffer and 3.3 μl
Proteinase K (18.5 mgml− 1) for 16 h in a water bath at 50 °C. Samples were
mixed thoroughly to break up any unlysed tissue and 1.65 μl Proteinase K
(18.5 mgml− 1) was added to the sample followed by 1-h incubation at 50 °
C. Proteinase K was inactivated by incubating samples at 65 °C for 30min.
Lysates were transferred to 2ml eppendorf tubes and extracted with
300ml of phenol–chloroform–isoamyl alcohol (25:24:1) buffered to pH 7.5
by inverting 20 times and centrifuging at 13 000 r.p.m. for 15min. The
aqueous layer was extracted twice with 300ml of chloroform–isoamyl
alcohol (24:1) in a new reaction tube, by inverting 20 times and
centrifuging at 13 000 r.p.m. for 15min. The aqueous layer was incubated
with 75 μl of 10 M ammonium acetate (NH4Ac) and 600ml ice-cold 100%
ethanol in a new reaction tube at − 20 °C for 1 h. The supernatant was
removed after centrifugation at 13 000 r.p.m. for 15min and the pellet was
washed with 1ml of 70% ethanol. DNA was pelleted by centrifuging at
13 000 r.p.m. for 10min. The pellets were left to air dry for 1 h and
resuspended in 100 μl of TE buffer. A NanoDrop ND-1000 was used to
quantify the DNA samples, and the quality and size of samples were
checked using a 1% agarose gel using gel electrophoresis.
Sodium bisulfite conversion
In all, 500 ng of genomic DNA from each sample was treated with sodium
bisulfite in duplicate, using the EZ 96-DNA methylation kit (Zymo Research,
Orange, CA, USA), following the manufacturer's standard protocol. The kit
exploits the three-step reaction that takes place between cytosine and
sodium bisulfite where unmethylated cytosine is converted to uracil. The
DNA was resuspended in 30 μl of distilled water and stored at − 20 °C until
further use.
LINE1 and IAP assay
We measured highly repetitive element methylation, blinded to epide-
miological exposure condition. Previously reported sequences of forward
and reverse primers of LINE1 and IAP38,39 Sigma-Aldrich were used for
analysis with the Sequenom EpiTYPER (San Diego, CA, USA), using
universally methylated DNA as a methylated reference (EMD Millipore
Corporation, Darmstadt, Germany), and an unmethylated DNA as negative
control. The LINE1 and IAP element assays were designed to cover more
than 600 000 genomic locations, which share a consensus sequence.40
Mecp2 promoter DNA methylation assay
Mecp2 promoter DNA methylation was quantified using the Sequenom
EpiTYPER platform, and primers for the target region were designed using
EpiDesigner (www.epidesigner.com, Sequenom). Six CpG sites were
quantified in an amplicon spanning 282 bp in the promoter and the first
exon (Please see Supplementary Table 1 for primer details). All EpiTYPER
assays were tested using a standard curve with methylated and
unmethylated DNA. Genomic DNA was isolated and 1 μg DNA was
bisulfite-treated as described above using the EZ DNA methylation kit
(Zymo Research).
Statistical analysis
Global DNA methylation was quantified in the two brain regions of interest
(the hypothalamus and striatum) from 22 PolyI:C-exposed and 17 saline-
exposed 6-week-old mice using the Sequenom EpiTYPER platform. The
sample characteristics are shown in detail in Table 1. The samples were
handled together to reduce experimental/handling bias at all stages of
experiments. In all group comparisons each animal was treated as an
individual subject. Both LINE1 and IAP assays measure a proxy of global
DNA methylation, and Pearson correlation testing was used to identify any
correlation between assays. A general linear model (GLM) was used to
identify any main effect of group or sex or any interaction with unpaired t-
tests to explore the data post hoc. Grubb’s test using extreme studentized
deviate method was used to detect outliers with an alpha cutoff 40.01.
The criterion for statistical significance was set as Po0.05 and analyses
were conducted using R (http://www.R-project.org/) and SPSS. The effect
sizes reported are the absolute change (delta) in DNA methylation.
RESULTS
Altered global methylation in the adolescent brain following
prenatal immune challenge
Quantitative DNA methylation was measured across LINE1
elements to give a proxy of global DNA methylation across
~ 600 000 repeats in the mouse genome.41,42
LINE1 methylation in the hypothalamus
There was a significant main effect of treatment (F (1, 36) = 5.72,
β=− 0.516, P= 0.022), with no effect of sex (F (1, 36) = 1.27,
β= 0.248, P= 0.266) on the mean LINE1 methylation, and 12.18%
of variance was explained with the GLM used. This resulted from
significant hypomethylation in the hypothalamus of the PolyI:C
group (69.66%, s.d. = 0.62) compared with the saline group
(70.19%, s.d. = 0.72; t= 2.44, P= 0.019, delta methylation = 0.53;
see Table 2), especially in females (t= 3.04, P= 0.005, PolyI:C group
mean 69.45, s.d. = 0.59, saline group mean 70.26, s.d. = 0.71, delta
methylation = 0.81).
Table 1. Animal numbers
Group PolyI:C Saline
Litter 6 weeks M1 M2 M3 M4 M5
Sex (male:female) 3:3 3:6 2:5 4:5 3:5
Total 22 17
PolyI:C group (litter M1, M2 and M3) and saline group (M4 and M5) with the
number of males and females in each litter. Animals used in the
experiment were, as far as possible, kept free from any interventions that
could further affect their epigenetic status.
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The first CpG in the LINE1 element in the hypothalamus was
differentially methylated in adolescent stage after PolyI:C admin-
istration in prenatal life, main effect of Group (F (1, 36) = 5.77,
β=− 1.503, P= 0.021). In all, 9.08% of the variance was explained
by the GLM used. There was no significant main effect of sex (F (1,
36) = 0.08, β=− 0.183, P= 0.775); however, there was a significant
Group x Sex interaction (F (1, 35) = 5.54, β= 2.846, P= 0.024) and
the GLM explained 19.27% of variance. This was explained by
significant hypomethylation in the PolyI:C group (t= 2.42, delta
methylation = 1.49, P= 0.02; PolyI:C group mean = 27.68%, saline
group= 29.17%, s.d. = 2.03). Again, differences were most pro-
nounced in females (t= 4.11, delta methylation = 2.62, Po0.001).
LINE1 methylation in the striatum
There was no significant main effect of group, or sex, or any Group
x Sex interaction on the mean LINE1 methylation in the striatum
(PolyI:C group mean = 70.79, s.d. = 1.15 and saline group mean=
70.41, s.d. = 1.01).
IAP assay
IAP promoters were not differentially methylated in the hypotha-
lamus or striatum in the PolyI:C and saline control groups, see
Table 2. LINE1 and IAP assays for the mean global methylation
were not correlated (P= 0.298, r=− 0.170).
Mecp2 promoter methylation
The mean methylation of Mecp2 in the polyI:C-exposed hypotha-
lamus was lower than in saline groups (PolyI:C group = 26.57%, s.
d. = 6.70; saline group= 34.63%, s.d. = 5.97). There was a significant
effect of group and sex in the mean methylation of the Mecp2
promoter region in the hypothalamus: (F (1, 26) = 24.08, β=
− 7.937, Po0.001) and (F (1, 26) = 34.49, β= 12.384, Po0.001),
respectively. In total, 67.18% of variance in Mecp2methylation was
explained by the GLM used. There was no significant Group x Sex
interaction. Post hoc tests confirmed Mecp2 promoter hypomethy-
lation in the PolyIC group (t= 3.39, delta methylation = 8.05,
P= 0.003) and in females (t= 4.35, delta methylation = 7.14,
Po0.001). Please see Figure 1 and Table 2.
Individual CpG sites 2 and 4 were significantly differentially
methylated in each group (F (1, 26) = 13.12, β=− 9.870, P= 0.001; F
(1, 26) = 11.71, β=− 6.244, P= 0.002, respectively) and sex (F (1,
26) = 10.84, β= 11.294, P= 0.003; F (1, 26) = 13.08, β= 8.604,
P= 0.001, respectively). The mean methylation for CpG site 2;
PolyI:C group = 20.35%, s.d. = 8.71, saline group= 30.33%, s.
d. = 7.24 and CpG site 4; PolyI:C group mean = 30.58%, s.d. = 6.21,
saline group= 36.91%, s.d. = 5.19. There was no significant Group x
Sex interaction. A total of 15.63% of variance in CpG 2 methylation
and 45.22% of variance in CpG 4 methylation were explained by
the GLM used.
Mean methylation of Mecp2 in polyI:C-exposed striatum was
also lower than controls but this difference did not reach statistical
significance (please see Figure 1 and Table 2).
DISCUSSION
This is the first study to directly examine the epigenetic
consequences of prenatal exposure to MIA in the adolescent
rodent brain. We found significant DNA hypomethylation in the
hypothalamus and a similar trend in the striatum of offspring
exposed to MIA compared with saline-exposed controls. In
addition, the Mecp2 gene promoter region was significantly
hypomethylated in the hypothalamus of MIA-exposed group but
not in the striatum. These effects were most pronounced in
females.
LINE1 methylation
Approximately 50% of the mammalian genome comprises the
retrotransposon-associated repeat sequences, with LINE1 ele-
ments and LTR elements (including IAP) accounting for 20%40
and 10%, respectively.43 LINEs are ~ 6-kb-long elements with an
internal polymerase II promoter encoding two open reading
frames and account for a great amount of somatic mosaicism.44
LINE1 elements transpose through RNA intermediates, assembling
with their own encoded proteins through reverse transcription.
LINE1 is highly active and can create indels, new splice sites which
fine-tune gene expression.45 LINE1 transposons may also disrupt
coding regions, and their epigenetic suppression by causing indels
is vital during the early course of development.46 Inappropriate
suppression caused by altered DNA methylation across these
elements may lead to adverse consequences in the adult life.47
Consistent with this role in development, LINE1 has been
reported to be differentially methylated and highly susceptible to
retrotransposition in neurodevelopmental disorders.25 For exam-
ple, hyperactive retrotransposition and higher copy number of
LINE1 have been reported in schizophrenia and observed in the
Table 2. PolyI:C and saline group comparison results of different assays
LINE1 IAP Mecp2
Mean s.d. P-value Mean s.d. P-value Mean s.d. P-value
Hypothalamus
0.696 0.006 0.265 0.067
PolyI:C F 0.694 0.005 0.935 0.014 F 0.290 0.037
0.019* 0.002**
M 0.700 0.005 M 0.148 0.042
F 0.005** 0.47 F 0.000***
0.701 0.007 0.346 0.059
M 0.885 M 0.202
Saline F 0.702 0.007 0.931 0.012 F 0.362 0.046
M 0.700 0.007 M 0.266 0.068
Striatum
0.707 0.011 0.930 0.050 0.295 0.179
PolyI:C 0.29 0.85 0.37
Saline 0.704 0.010 0.936 0.066 0.345 0.121
Abbreviations: F, Female; IAP, intracisternal A particle; LINE1, long interspersed elements; M, Male; Mecp2, Methyl CpG Binding Protein2. Mean methylation of
all the markers for each assay. *Po0.05, **Po0.005 and ***Po0.0005.
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polyI:C MIA model.48 Our observation of LINE1 hypomethylation in
the same MIA model would be expected to increase retro-
transposition and may provide one possible path linking
inflammation with the increased risk of schizophrenia.
Altered DNA methylation as a potential mediator of environ-
mental risk for neurodevelopmental disorders fits with evidence
from other systems. For example, prenatal exposure to the
antiepilepsy drug valproate is associated with increased risk of
autism spectrum disorders in the offspring,49 and this drug has
been recognized to cause widespread epigenetic reprogramming
especially DNA hypomethylation.50
IAP methylation
IAPs are autonomous retrotransposon elements with long
terminal repeats and all the necessary transcriptional regulatory
elements. These class-II endogenous retroviruses transpose
through retroviral mechanisms in the cisternae of the endoplasmic
reticulum.51 IAPs add a significant amount of genetic variabilities
to the genome with differential tissue-specific expression and are
capable of interfering gene function in the brain.52,53 The
complexity and the size of IAP make it less common and less
likely to occupy the vital regions in the genome. Thus, IAP assays
target completely different elements than LINE1, with a lower
representation over the genome,54 which may account for the
sparsity of findings using this assay in our study, and the lack of
evidence linking IAP alterations with neurodevelopmental
disorders.
Mecp2 methylation
MECP2 has a well-established role in Rett’s syndrome but has also
been implicated, by our group and others, in idiopathic
neurodevelopmental disorders such as autism and
schizophrenia.55,56 MECP2 is an abundant neuronal protein that
indirectly mediates gene transcription by recruiting transcription
factor cAMP responsive element-binding protein 1, depending on
the methylation status of the DNA.27 This action alters the
expression of many genes in the hypothalamus57 and beyond,
including LINE1. Aberrant promoter methylation of MECP2 itself is
thought to contribute to a defective biological network and
potentially to the etiology of neurodevelopmental disorders.58
Here we report a significant association between MIA and
Mecp2 promoter hypomethylation. The polyI:C used in this MIA
model is known to cause an increase in IL6.59 MECP2 in turn may
suppress IL6 expression;60 therefore, we speculate that hypo-
methylation, leading to a higher level of MECP2, may be involved
in silencing genes that are activated by the immune response.
Changes in Mecp2 could theoretically influence the expression of
other developmental genes previously reported to be altered in
the MIA model, for example, brain-derived neurotrophic factor61
and Reelin, Glutamate decarboxylase 6762 and cAMP response
element-binding protein;63 histone deacetylases and DNA (cyto-
sine-5)-methyltransferase 1.26,64 A theoretical construct showing a
functional protein association network potentially influenced by
MECP2 is shown in Supplementary Information and Figure 1.65
More specifically, in terms of the dopamine system, closely
linked to disorders such as schizophrenia, we speculate that
removing a methylation ‘brake’ on Mecp2 gene expression would
promote or even overdevelop dopaminergic neurons. This is
because the converse - low levels of MECP2 in dopamine neurons
- results in fewer dendrites, less membrane surface area and even
a compromised nigrostriatal pathway.66
PolyIC caused greater LINE1 hypomethylation in the hypotha-
lamus of female offspring; however, although the Mecp2 promoter
was more hypomethylated in females in both polyI:C- and saline-
exposed groups, there was no significant Sex x Group interaction.
Although neurodevelopmental disorders such as autism are
generally more prevalent in males than females, this is not the
case for schizophrenia,67 and Rett syndrome is predominantly
diagnosed in females.68 Moreover, consistent with our results,
genome-wide methylation studies of schizophrenia and other
psychiatric conditions have reported global hypomethylation in
females.69,70 This excess of epigenetic modification in the female
sex may also be relevant to the suggestion that environmental
exposures are relatively more important in females with neuro-
developmental disorders.71
Regional methylation changes
Hypomethylation of Mecp2 and LINE1 in an adolescent offspring
exposed to MIA was most pronounced in the hypothalamus.
Hypothalamus–pituitary–adrenal axis developmental changes,
and especially hypothalamic dopamine systems, are strongly
implicated in the onset of schizophrenia.35,72 Consistent with this
evidence, MECP2 has been found to mediate dopaminergic
precursor differentiation in the ventral midbrain especially in the
developing hypothalamus via Dlk1.73 Similarly, aminergic neuro-
transmitter concentration is regulated by MECP2 through rate-
limiting enzymes involved in synthesis and degradation, which
may contribute to phenotypes relevant to schizophrenia and
autism.74
The direction of Mecp2 methylation differences in the striatum
of MIA exposed mice relative to controls was similar to those
observed in the hypothalamus; however, group differences did
not reach statistical significance. We also observed a main effect of
sex - females were generally undermethylated relative to males in
Figure 1. Hypomethylated Mecp2 promoter in the hypothalamus of PolyI:C-exposed offspring. y axis shows methylation in percentage with
error bar as s.e.m., histograms represent saline- and polyI:C-treated male and female groups. (a) Mecp2 promoter methylation in the
hypothalamus of polyI:C- and saline-exposed male and female groups. (**P-value is calculated from a stratified t-test between saline- and
polyI:C-affected females). (b) Mecp2 promoter methylation in the striatum of polyI:C and saline-exposed male and female groups.
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both PolyI:C and control groups in both regions of interest. Thus,
whereas low power may have limited any group differences in
methylation in the striatum, it is also possible that lower
methylation in females of both groups may have obscured group
differences in methylation in the striatum.
Advantages and limitations of the study
An organism’s phenotype is produced by its genotype’s interac-
tion with the environment and thus epigenetic changes influence
gene expression, DNA repair and recombination. Under the
influence of these epigenetic mechanisms, genetically identical
cells, tissues and organs show variation and become unique
during the course of development.75 However, investigating
epigenetic etiological mechanisms in the brain, and under-
standing the effect of epigenetic modifications resulting from
the prenatal assaults in humans, is extremely challenging. This is
partly because studies are indirect, relying upon peripheral blood,
buccal swabs and other tissues.
Therefore, animal models can help to better control the
environmental exposures and homogeneity of the sample. More-
over, the animal model allows DNA isolation from specific regions
of the brain. This is important because patterns of DNA
methylation are region- and tissue-specific,76,77 and peripheral
tissue samples collected in humans are unlikely to reflect what is
happening in the brain.78 However, although animal models allow
us to sample brain, there are still technical constraints and it must
be acknowledged that assays such as LINE145 and IAP provide
only a proxy of global methylation.6
We also accept that the current study targeted restricted
regions of the brain; therefore, we cannot say whether our
findings are truly region-specific or more generalized. Even
though carefully dissected out, DNA was isolated from tissue
comprising a mix of cells with possibly different epigenetic
profiles. Assays of single cell or minimal numbers of isolated cells
could have improved cell type accuracy but also have restricted
generalization. Furthermore, we used LINE1 and IAP assays only to
obtain a proxy of global DNA methylation. These assays cannot
reveal the individual genes affected, nor tell us whether the
differences observed have functional implications. Future work
will need to be conducted to ascertain the functionality of these
methylation changes (especially the significant, but very small,
group difference in LINE1 DNA methylation in the hypothalamus).
Finally, we acknowledge that alternative design would be to
consider each litter as a single experimental unit with the
assumption that the exposure of fetuses within one litter is
identical. However, this assumption may not always hold as each
fetus in the mouse uterus has been shown to have a distinct blood
perfusion pattern;79 therefore, exposures may not necessarily be
identical. On balance, we wished to optimize genetic similarity so
that the focus would be on environmental exposure. We therefore
elected to treat each an offspring as a ‘subject’, and enter data
from each littermate separately into the analysis.
Summary
This study examined epigenetic differences in the hypothalamus
and striatum of the adolescent brain following exposure to MIA in
prenatal life, a risk factor for schizophrenia and related neurode-
velopmental conditions. We observed differences in both global
methylation and Mecp2 promoter methylation that may have
relevance to neurodevelopmental disorders. In particular, hypo-
methylation of the Mecp2 promoter may have widespread
repercussions on gene expression and deserves further explora-
tion as a possible biomarker for environmental modifications
linked to prenatal assault. Further exploration of epigenetic
mechanisms operating in neurodevelopmental conditions is
warranted because these gene modifications are potentially
modifiable and this approach may open new avenues for
treatment.
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